Reddit Posts
Sony Calls Off $10 Billion Merger With Indian TV Giant Zee Entertainment Enterprises
MedBright AI (MBAI.c MBAIF): 9 Clinics, 3 Provinces, 21 Dermatologists, 5 Mohs Surgeons, 2 Plastic Surgeons, and 13 General Practitioners
Integrated Cyber Solutions Inc. Provides Status Report of Annual Financial Statements and MD&A (CSE: ICS)
Luca Mining Corp. $LUCMF (otc) or $LUCA (tsxv) Filed their financial statement but it wasn't picked up by the news services
American Aires Inc. Announces Positive EBITDA with Its Filing of Q3/2023 Financial Statements, and MD&A
American Aires Inc. Announces Positive EBITDA with Its Filing of Q3/2023 Financial Statements, and MD&A
Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC
Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC
Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC
Breaking news: Novel triple combination developed by CanBas shows promise as third-line treatment in patients with metastatic PDAC
GFH009 / SLS009 is Shaping up to be a true Miracle Cure for AML patients
MBRX - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinical Trial Demonstrating 64% Stable Disease Rate Through Two Cycles of Annamycin for the Treatment of Soft Tissue Sarcomas (STS) Lung Metastases
Small account growth over October. SEDG, ENPH, LMT, SPY, NVO.
Critical Infrastructure Technologies Ltd. Announces Late Filing of Annual Financial Statements and MD&A (CSE: CTTT, OTC: CITLF)
ReconAfrica Annual General Meeting - Inaugural Presentation by New CEO Brian Reinsborough
ReconAfrica Annual General Meeting - Inaugural Presentation by New CEO Brian Reinsborough
Astra Energy Inc. Reaches Agreement with Holcomb Energy Systems to Secure Exclusive Worldwide Manufacturing Rights on Revolutionary Technologies and Welcomes Dr. Robert Holcomb MD, Ph.D. to Its Board of Directors
The price of Avalo Therapeutics (AVTX) rose 69% on Wednesday. Why is that so?
$TCO comparing the gold and copper grades of one company, with depth, to other companies
Nextleaf Solutions CSE:OILS Q3 MD&A financials are on SEDAR
Adastra Holdings (CSE:XTRX)(FRA:D2EP) Releases Q2 2023 Results - Record Quarterly Revenue of $10.9m
Summa Silver: Excellent Metallurgical Test Results from its Hughes High-Grade Silver-Gold Project
Can someone justify the existence of fund managers to me?
PRESS RELEASE: Citius Pharmaceuticals Reaches 92 Event Milestone in Mino-Lok Phase 3 Trial
Sen. Chris Van Hollen (D-MD) says lawmakers are "working to resolve some final issues" before they can vote on SAFE in committee.
ReconAfrica Netherland Sewell Resource Report & Updates on New CEO Brian Reinsborough
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
Q2 Sales Data Headset - never mind safe lets focus on Sales
$RHT.v / $RQHTF - Reliq Health Technologies, Inc. Announces Successful AI Deployments with Key Clients - 0.53/0.41
Trulieve Sparks Maryland Recreational Sales on July 1 in Halethorpe, Lutherville and Rockville, MD
This pennystock has the potential to become a multibagger depending on the sales of assets deal
Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System
Does dividend investing become a better long term option than growth investing at low income?
Summa Silver Reports Great Metallurgical Test Results from Mogollon Project
($BCNN) Management Discussion and Analysis – Outlook 2023
($BCNN) Management Discussion and Analysis – Outlook 2023
*buzz* Mega MOVE UP and Mega DD on Atossa Therapeutics (NASDAQ: ATOS)
Lille.ai is Launched: Generate Communications With Full Traceability and Control
$MKT.v at $0.015 on the TSX-Venture (Canada) getting serious attention this morning. Perhaps an Artificial Intelligence announcement soon.
$FOLGF Huge audited financial report is getting attention..
$BXRX Shorts playing a dangerous game here..as News yesterday was huge..not to be overlooked..
Looking for recommendations to get into options trading
PaxMedica, Inc. (PXMD): A Company Profile
Understanding PaxMedica, Inc. (PXMD): A Deep Dive
An Overview of PaxMedica, Inc. (PXMD) and Its Operations
Toast Inc. ($TOST) stock initiated by Deutsche Bank analyst, price target now $20
MET.v is on the Cusp of a buyout with an 80% upside
American Aires Inc. Announces Filing of 2022 Financial Statements and MD&A
Help to prepare for an junior equity research interview
Alright tardnadoes, who wants to make some money? Yes? Then here is my DD on biopharm company ARDX, which stands at 975M market cap and is poised to double in stock price this year (maybe).
NVIDIA Co. (NASDAQ:NVDA) Shares Purchased by Polaris Wealth Advisory Group LLC
Enterprise Group ($E.TO, $ETOLF.OTC): Cash Flow Machine, Deep Value, Squeeze Potential
Kim looks like an MD who’s advising on Jiffy Lube’s merger with Valvoline
Market News Today: Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma
BTCS Shares Set to Split on Friday, March 24th.
10,000 Shares in Toast, Inc. Acquired by Marathon Capital Management
BTCS Share Price Passes Above 50 Day Moving Average of $1.40
Canada Pension Plan Investment Board Purchases 87,300 Shares of Toast, Inc.
Global Payments Price Target Increased to $120.00 by Analysts at Mizuho
Now we can see why this Mr. Chadha of BoB is willing to help Adani at any cost. Did you? Ok, let me explain, Before joining BoB, he was the MD and CEO of SBI Capital Markets Ltd.(investment banking arm of SBI). So it looks like the man already helped Adani when he was in SBI. Any thought?
StakeSeeker by BTCS Now Offers Automated Reward Compounding Through New “AutoStake” Feature
A great opportunity in my view to invest in a small oil company with good cashflow which last Friday started to market itself to investors, using Newsfilecorp to push press release online. Sounds like we can expect more press releases to follow.
Diving Deep into Immix Biopharma, Inc. (IMMX)'s operations
Valuing Aduro Clean Technologies (OTC: ACTHF)
A Brief Look Through BriaCell And Their Heroic Fight Against Cancer
Rodedawg International Industries, Inc. (OTC: RWGI) Provides Shareholder Updates 2023 Revenue Growth, Launches New Product, and Gains New Dispensary Outlet
ENSC - Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection
Immix BioPharma (NASDAQ-CM: $IMMX) Developing a new class of tissue specific therapeutics
Continuous advancements in the biopharma field: Immix BioPharma (NASDAQ-CM: $IMMX)
Cannabis – The Entourage Effect: Dr Ethan Russo MD, Doctor & Researcher (Altmed Ep.80)
$GSTC Globestar Therapeutics (Multiple Sclerosis Biotech Clinical Trials)
Immix BioPharma (NASDAQ-CM: $IMMX): Servicing a market that is always in need
BioPharma historically stable during down markets: Immix BioPharma (NASDAQ-CM: $IMMX)
Invictus MD Strategies Special Meeting Dec 12 2022
House Republicans and Democrats Publish “Joint” memo on Marijuana Legalization Ahead of Congressional Hearing - MSOS ETF
White House Unveiled $2 Billion Biotech Spending Plan - Immix BioPharma (NASDAQ-CM: $IMMX)
Therapeutic Solutions International ($TSOI) Spin-Off Res Nova Bio Collaborates with Veltmeyer MD Inc. to Provide Breast Cancer Patients Access to Novel Cancer Immunotherapy. First in Class Antiangiogenic Immunotherapy Offered under Right to Try Law to No Option Patients.
A Profitable Pot-Stock that is Priced for Liquidation
The Most Undervalued Stock on the Market
Credit Cards to $3,000,000 in realized profit to $2,500,000 loss in 6 weeks.
ESE Entertainment - It's almost time for Earnings (TSXV:ESE | OTCQX:ENTEF)
Lomiko Metals $LMRMF Hts New High Grade Zone - Starts European Road Shw
$TCRT CURED CANCER. Deadass Serious. Warning: Actual Due Diligence Inside.
Mentions
The recent GradPlus loan changes have capped total loans at $200k for professional programs (like MD). This means fewer people can become doctors. The recent GradPlus loan changes have capped total loans at $100k for non-professional programs (like CRNA, NP, and PA). This menas fewer people can become the people that reduce doctor workload. Our future: * Fewer doctors * Fewer advanced healthcare pros who reduce doctor workload If the loan limits aren't fixed ASAP, this is going to have devastating effects on healthcare.
A federal bill designed to block marijuana businesses from claiming standard tax deductions even if marijuana is rescheduled has gained its 15th sponsor in the House and Senate, and its second new sponsor this week. House (HB 1447) * Jodey Arrington (R-TX) * Vern Buchanan (R-FL) * Blake Moore (R-UT) * Gregory Murphy (R-NC) * Adrian Smith (R-NE) * Nathaniel Moran (R-TX) * Charles Edwards (R-NC) * Gary Palmer (R-AL) * Pete Sessions (R-TX) * Andy Harris (R-MD) * Andrew Clyde (R-GA) * Michael Lawler (R-NY) Senate (S. 471) * James Lankford (R-OK) * Pete Ricketts (R-NE) * Ted Budd (R-NC) * per MM
These days, the boards are filled with these healthcare jobs requiring a MD or DO along with board certification that pay only $190k
Hello. James Mason, MD at Philedelphia Logistics, but you may know me as u/BumsRFunny5797, moderator on r/butt_plugs
#TLDR --- Ticker: HIMS Direction: Up Prognosis: Long Shares & LEAPS for March 2026 Credentials: "Regarded MD" Secret Weapon: Liposomal delivery (bypasses Big Pharma patents) Strategy: OP argues Hims is playing 4D chess. The recent product "pull" was a publicity stunt. Hims is partnering with Strive Pharmacy to use liposomal technology, which bypasses Novo Nordisk's delivery patents. With a major GLP-1 patent expiring in March 2026, Hims is positioning to legally flood the market with generics while using the current price crash to execute cheap buybacks.
You forgot these gems -Supreme sales license (any day now) -Hadley Ford at Ianthus -MARI/WAYL and Ben Ward Fleeing the country -Gene Simmons (Invictus MD) -THC Biomed and the [Ferrari](https://old.reddit.com/r/weedstocks/comments/60dvbw/outside_of_thc_biomed_i_see_this_ferrari_often_is/) Its fun to go look at press releases, scams and all the things happening 8 years ago.
👆not true! I am also a pharmacist. Please actually read the law congress passed regarding compounding medication. MD can prescribe compounded medication if necessary and it has explicitly stated it’s up to the prescriber. That is why we do semaglutide with vitamin b12 because b12 has shown some patients have no side effects to drug. Plus we can give different less dose to titrate. You think Iam bullshit? then go prove. That is what courts been saying. prescribing md do not have to prove.
Bottle of MD 2020 and those fingerless wool gloves
What's your yoe? No offense but that is a terribly innocent take I'm 9yoe, I can feel the damage in doing dictating instead of writing, key core areas id know by heart I now generally know what they do, not specifically 1000 lines of Claude MD docs are not adequate to describe 1m loc
I am a doctor, Mantis Tobagin MD
FDX. Pretty clearly gapping upwards the last few days and had an utterly massive target upgrade from $295 to $380. Pretty glad I hopped on at $300 because there's a ton of positive catalysts going for it right now (likely MD-11 return in March-May, Freight spinoff adding $20B in value just to existing shareholders alone, and record profitability and increasing efficiencies of scale).
First you get a PhD in economics/finance/computer science/math, then you would at a finance company with a team made up of some of the world's smartest humans where you conduct thorough, advanced analysis over the course of weeks/months/years. Or perhaps you have some advanced degree (MD, engineering, etc.) which gives you some special insight into the impact of some startup that others haven't seen yet. Otherwise, buy VT. You are not going to be able to compete with finance groups spending literally millions of dollars on large teams of world experts trying to answer this question.
My buddy's gay stripper name was Rich Sparkle, Dr. Wewe MD
As someone who actually works at an airport, CRJs aren’t “aging airframes”. MD-80s and -90s? Yeah 737-300, -400, and -500s? Sure. The A300-600s I work on (that ceased manufacturing in 2007, and most of the airframes I work on began their lives in the 1980s)? *Definitely*. But the CRJ line only ceased manufacturing in 2020. They are by all measures, *very* modern aircraft. They began manufacturing them in 1991 with the 100/200, and most models still flying are the more modern 700/900/1000 (and other variants) that only started production in 1999. Hell, practically all 737s, 747s, 757s, 767s, 777s, and even some 787s are older.

You're an MD, pick up an extra shift and you'll have it back 👍
I sold a while ago to reposition to AMD and semiconductors overall. I still think Nvidia has upside but MD is better position to take market share and Nvidia may lose pricing premium in the coming months and years which has driven their crazy profitability
I’m conflicted because it is the earnings season that covers the holidays which is the busiest time of the year in the package industry, but I don’t know if that plane crash and their MD-11 fleet being grounded will be enough to cause a serious earnings miss. I might do 2 puts lol.
Nah, where is the moat on Meth? Despite it now having 50% marketshare, Meph and MD are coming for it like Apple pay and Klarna for Paypal.
Oh ok. Yeah, U should not leave a trade opens, when leave your computer, when U are day trading. Does the trading platform that U use, give U the ability to set "Trailing Stops"? 
Mid caps and small caps have worked well if you bought in the past six months. VXF IWM the Russell MD or mdy etf.
The MD of my trading desk laughed at me when I said I full ported IMSR at 7. Today everyone was spamming +25% in the desk chat. Fat W.
Great question. NAKA kindly MD is a bitcoin treasury company that fits this scenario except Bitcoin instead of land. I own some
I'm in academia, so I am in the loop of what breakthroughs people are actively researching, not so much on which companies take up the research and commercialize it afterwards. I know people accross the street from me, in MD anderson cancer center are making a lot of breakthroughs lately, but as you probably know MD anderson is not a tradable company, although I do believe they sell the drug candidates and commercialization rights to proper pharma companies which then put them out in the market. I can provide advice on whether the science behind some hyped biotech is feasible, or if it has better alternatives, **but** chatgpt can probably tell you which drugs have been taken into clinical trials, what stage they are in, and which companies are capable of scaling them enough to get FDA approval and create significant streams of income, much better than I can.
How will i get through the day 😒 u/Joe_Early_MD is permanently banned from r/OUTFITS
I only vote Republican -Michael Beary, MD
The only thing GLP1 agonists and IL-15 agonists have in common is that they’re agonists…comparing this drug to GLP1 agonists is ridiculous. GLP1 and IL-15 have literally nothing to do with each other. IL-15 isnt some secret. Agonizing it does stimulate the immune system but many cancers grow specifically because they avoid the immune system. So T cells and NK cells won’t do shit. It’s likely a great add-on treatment, but only if the cancer hasn’t already mutated to the point of avoiding the immune system. That’s why CAR-T therapy is so effective, it’s essentially extracting the patients T cells, then training T cells in the lab to target and attack cancer cells by using crispr to add the gene coding for a marker in the cancer cells, then reintroducing the modified T cells to the body. I know and worked in the same lab as a doctor (PhD MD dual degree) who’s pioneered CAR-T therapy; now he’s an expert. Sadly CAR-T isn’t a profitable drug but rather an expensive procedure, so profits are low but it’s the literal cure to cancer, due to its highly personalized nature. Since every cancer is different, there’s no one size fits all approach, but I digress. If your T cells are blind to cancer cells, which happens a lot, activating them won’t do anything. This drug, like many others, is a gamble. I work in biotech and have developed cancer therapies fwiw, and know much more than the average redditor…who knows nothing about biology besides a high school class they slept through. I don’t consider myself an expert, but my definition of an expert in this case would be someone who has a phd in cancer biology or immunology at the least, plus relevant research experience. And no, being an expert in IT or CS or finance doesn’t make you an expert in cancer biology and immunology.
While I was in graduate school, we lived next to a MD who was doing his residency. His comment was, never invest in what an MD invests in. His rationale was that MDs. Have lots of money but very little time to think about their investments… and so they made lots of really bad investments.
You have no idea about his skill set, he could be a lawyer or MD for all we know. Not every industry has a completely fucked job market
For it's size the MD-11 carries more cargo than anything else. It's smaller size allows it to operate out of a wider variety of airports. There's a reason it was still used for cargo it's not easy to replace. The accident aircraft also wasn't even made by Boeing. McDonald Douglas still existed when N259UP was made in 1991 but Reddit won't care about that either it's all $BA's fault
MAXQ is canadian penny stock, gonna be the first satelite launch pad in Canada most likely, up 50% this month so idk if i'd wait for a dip or what though MD Space is also a Canadian space stock and they invested into MAXQ i hold both as a combo

House MD has been over for 13 years
Thank you for being a responsible parent. You’ve done him a solid. My dad left me with debt. problems and more problems. But it’s okay, I was resilient. I got my MD, started saving from 18 and I luckily found a bf who paid all my bills and student loans. So i’m not complaining! Even a bad hand doesn’t mean you’ll have a bad life.
My firm had an ex-politician like an Eric Cantor, he was very hands-on and made sure everyone knew he wasn't just a 'Vice-Chair', but also an MD. Funnily enough, they hired his political 'Chief of Staff' too as an MD and he washed out pretty quickly because he just wasn't skilled in finance. I remember one night staying late to help him with a pitch for an infrastructure deal - up his alley because it involved political influence...but he was lost on the finance side. I wasn't apart of that group at all but we were casual friends and I wanted to try to help him. I think he went right back into politics.
Am not defending her, but given goldman’s array of products etc, my guess is she was not in your traditional IB vertical. Although Eric Cantor very much acts like a traditional IB MD from what I’ve been told, so could be wrong
As much as it might be shitty for someone to get an MD role with precious little finance experience… If her ‘role’ was effectively to make life easier for GS, then they get what they effectively paid for…
Life MD-- I'm livid! Please file with BBB! [https://www.bbb.org/us/ny/new-york/profile/telemedicine/lifemd-inc-0121-183749/complaints](https://www.bbb.org/us/ny/new-york/profile/telemedicine/lifemd-inc-0121-183749/complaints)
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
fellow docs of reddit, does anyone use doximity other than for the dialer? MD here
Ivy League? Masters? MD/JD? Start now and MAXOUT! If you’re lucky you’ll have 500k in her 529, she’ll get full academic/athletic scholarship. Then you buy a house after you take 35k for Roth. Take 10% tax hit w capital gains but who cares because you now buy her a house w cash!
You are a moron, I am shocked you were able to spell half the words in that, must have used ai to proof it. First, Keytruda started with ONE indication when it was approved (like almost every drug) and it was for an even more rare type of cancer. It now has 42 indications across 18 types of cancer, that is called expanding the use of a drug through continued trials. Apparently you aren't aware of that process. Second, SLS has two therapies, one that treats WT1 and another that is a CDK9 inhibitor. I will keep it very simple for you as you are a simple audience. These two proteins show up in a combined 35-40 types of cancer. Both of the therapies are blowing away the BAT competition in cancers that other drugs are afraid to even test in, let alone actually have an indication for. Thirdly, these are on pace to be the first two therapies approved as part of the early AI research done in the late 2010's. The first therapy was discovered by Memorial Sloane Kettering, I don't expect you to know who they are but they were recently recognized as the top cancer research center in the World, they are not a joke. Sellas is partnered with the likes of MD Anderson and MSK for their trial sites and several of the lead physicians are recognized as the top researchers for AML. I hope you short the hell out of SLS, post your position, keep going deeper and deeper into a position for a company you have no understanding of. Good luck.
UPS and FDX could go absolutely nuts depending on the timing. Current events impacting both that could end up happening near simultaneously: SCOTUS tariff ruling, if the tariffs are stricken, this means huge increases in shipping volumes. FDX is spinning off Freight into FDXF… *in June*. This coincides with the SCOTUS schedule. Both FDX and UPS are expecting the FAA to return the MD-11 to service in Q1-Q2, likely based on how the crash investigation is proceeding. That will be a 10-15% boost to their air fleets and could end up timed simultaneously to both the SCOTUS ruling and FDXF spinoff. The MD-11 grounding and tariffs are fundamentally what has hammered UPS down from >$200/share to now hovering around $100/share. If the tariffs are repealed and the MDs return to service at the same time, we could see a 100% rally in value for UPS simply as it returns to its normal trading position. Prospective increases due to trade increasing are expected to lead to between a 30-40% rally across the shipping sector as well, and the FDXF spinoff will come with a distribution of shares to existing shareholders (basically, you could get free shares timed right at an increase of 30-40% across both FDX and FDXF). TLDR: tariffs end = trade increases = significant shipping sector rallies.
https://preview.redd.it/cewqp88t59bg1.jpeg?width=2405&format=pjpg&auto=webp&s=8c617945b1ccdcbe51317e86847725315e8e4139 Dr. Kantarjian, the Leukemia Dept. Chair at MD Anderson pumping enrollment in the SLS phase 3 trial.
Why did MSKCC license their GPS program out? Why did MD Anderson terminate their sponsoring of GPS Osotspa failed their Phase 2 and nether bothered to start another one Also why did MRK and BMY bail on GPS combo trials instead of advancing to Ph3? Why did 3D Med skip paying the milestone to in-license it? It is because the data just was not good enough.
Three prior Big Pharmas (Memorial Sloan, MD Anderson, Osotspa) abandoned GPS partnerships after underwhelming data, hardly a vote of confidence, even with heteroclitic tweaks. They've run about 10 trials, only one of which was an RCT showing very mild benefit, unpowered for stats. OCV-501 already failed OS vs easier PBO despite T-cell induction, just like GPS's inconsistent responses in AML/MDS. https://preview.redd.it/cqpq5gkei7bg1.png?width=864&format=png&auto=webp&s=109d287aca8642856025b40daea42c301e2e9160
LOL. Lemme guess — VP of mom’s basement, vying for MD of cum socks. Share a LinkedIn or save it for Truth Social, liar
Not MAGA, I’m actually a VP, soon to be MD on Wall Street. Literally analyze stocks for a living. Let me ask you, what do you do besides play with yourself? I suggest you sit down before I really embarrass you. And to address your literally irrelevant articles, why don’t you look up what percentage of Canada’s GDP comes from America, or England’s or anyone’s. You should really not be allowed to post on this sub. There should be an intelligence requirement
I’m in PA but I do returns in WV, VA and MD too
Maybe I should. Although I will say, I don't think my profits on that business get close to 75k a year any more. More like 30. Although some years I do really well. But yes, all of these conversations lately have made me realize I probably need somebody who's a bit more savvy when it comes to tax situations than just a small business accountant. Are you licensed in MD??
You may have slipped through the cracks. I haven't had a bad experience with Schwab over the past 8 years per se but my father did have a hard time getting some legal questions regarding assigning full trading authority of his inherited trust to me. Between the originating office in CA, the local branch for him in MI, the local branch here in MD and the central office in TX, they lost track of his requested review internally and took about 2 months to approve the FTA request but customer service was always there to talk to..... It was just that the right hand didn't know what the left hand was doing. I started with a robo advisor when I opened my Roth with Schwab but switched to self directed. I'm sure that over the long run, it would have set me up well for retirement but as I learned more about investment strategy and products, I decided to switch to self directed.
Michael Beary, MD: if your puts move against you, I recommend starting a substack to try to survive, in my experience you can make up to $10M/month this way
I hope your MD buys this as why you've been playing RuneScape at your desk all day.
When you disavow false idols: * Michael Beary, MD * 🥭 * Ryan Cohen * Joe Rogan * DFV
Michael Beary, MD finally got PLTR down too, his work here is done
Pause. You’re 18yrs old considering loading up on 200k in grad student loans? DO NOT DO IT unless the grad school in question is medical (e.g., MD, PharmD, DSS), a T15 law school, or a PhD in niche engineering fields like nuclear. Just don’t. If it isn’t one of those, you’re making an irrecoverable financial mistake.
More like MD20/20, Sixlets, and RC Cola
The world *isn't* fair, but that doesn't invalidate **all** hard work. My wife grew up poor as shit in a rural, one stoplight town and is the only member of her family to go to college. She's making $150k+ right now with her doctorate. Her friend, who got an MD, makes like three times that working a couple hours a day as a clinical psychiatrist. Both of them had no connections, no family money, and aren't white men. You absolutely *can* work hard enough to be successful in the US. Just not in retail or food service, which can be both physically exhausting and shitty pay.
That's true, they restructured their debt. But with all the investments that they required to upgrade their facilities (check their recent MD&A) they did not have adequate funding for those improvements.
*blogging accelerates* -Michael Beary, MD
IonQ what a scary Computer hardware company lol Poor Performance metrics but a trajectory of growth that wants to go from $43 to $135 in the next two years The Profitability really really stinks but the price is good The momentum is gangbusters right now and the growth is a huge question mark It really started to ferment Sept 2024 and said up up and away in the hot air balloon 11 analysts are on it and they think +40% gains and the metrics says +54% it's like they think this company at it's worst over the next year can't go down, but only up will it go from $50 to $80? It's got poor quality of earnings and could be a possible manipulator of the numbers so it'll be an interesting trip to watch this one out IonQ Incorporated 4505 Campus Drive, College Park, MD, USA, 20740 IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services. ........ youtubey IonQ Stock in Freefall. Here's Why. 2 weeks ago Ion Q has been falling a lot lately which has some investors asking why the answer is quite simple it's the market. Is the quantum computing bubble finally popping? IONQ stock recently lost 50% of its value from the recent peak back in mid-October. Of course, this is much too short of a time frame to make any meaningful conclusions, but it's still causing the degens to worry. Today, we'll discuss the reasons why IonQ stock crashed, including their absurd valuation and reliance on growth by acquisition. Is IONQ stock a buy? Let's find out. \[link can't be posted in this thread\] definately a creepy looking tuber either a stock analyst or a serial killer ////// For the third quarter of 2025, the company reported the following key figures: **GAAP Operating Income**: A loss of $168.8 million, which widened significantly from the prior year. **Net Loss**: A substantial net loss of approximately $1.1 billion. **Adjusted EBITDA Loss**: An adjusted loss of $48.9 million. **Revenue**: Revenue was $39.9 million, a 222% increase year-over-year.
Since the plane crash and grounding of the fleet MD11 lift capacity is reduced. Ups told Amazon we want less of the volume pre crash Now ups is negotiating to get back the volume. They need revenue the operating costs increased leasing planes and equipment to get back lift capacity. The air gateways say they see increasing airfreight shipments. UPS trying to get as much revenue as they can get
*I’m back. Subscribe for more tips* -Michael Beary, MD
I DECLARE BANKRUPTCY -Michael 🐻y, MD
*cries* -Michael Beary, MD
That is completely insane. By the time you hit MD, you'll have massive amounts to take out. Even CFPs which is a joke of a license, suggest 4 to 5% a year. Yours is 3%
A major challenge for new data centers is securing sufficient, stable, and affordable power. Alcoa has several temporarily or permanently closed industrial sites that possess large, existing power capacities and grid connections, which are attracting big tech companies and AI developers. In Burrell, PA - a developer named TECfusions has proposed building a massive data center and AI campus on the site of the former Alcoa research facility, with plans for up to 3 gigawatts (GW) of power capacity. In Frederick County, MD - Alcoa sold its former Eastalco Works aluminum smelting plant site to a joint venture between Quantum Loophole and TPG Real Estate Partners in 2021, which is now being developed into a gigawatt-scale data center park. 3 more potential sites are being looked at currently for it's large power-grid connectivity.
AI is just a fad bro -Michael Beary, MD
home prices have been going down for like 6 or 7 months now, at least where I am, in the northern VA/MD area.
hopefully his MD can answer the question everyone wants know the answer to.........how can he have his head up his ass and still be able to breathe
Maybe you’ve heard of my step brother, Michael Beary MD
I didn’t know I needed the 1996 MZ-R4ST MD Walkman but here we are
be Michael Burry >born 1971 in San Jose, CA >age 2, get eye cancer, lose the whole thing >rock a glass eye >have no depth perception but still play football >high school: Santa Teresa, ace everything, zero friends (for the character arc) 1990s: >UCLA econ + pre-med >obsessed with stocks >start posting value picks on obscure forums >become message board mod >get noticed by Vanguard and Joel Greenblatt >start a fund 1997: >Vanderbilt med school >MD achievement unlocked >Work as a doctor while moonlighting as “Dr. Doom” on stock forums >Stanford residency in neurology > gets bored of med >quit med career >take entire inheritance + family loans and launch Scion Capital 2000-2007 >Scion returns 489% crushing $spy >spot housing bubble before everyone else >beg banks for credit default swaps on subprime mortgages >"Uh, we want to bet the house burns down?" Banks: "Lmao sure, weirdo" >investors riot: "You're insane, gimme my money!" >raise gates in a side pocket so they can’t withdraw funds 2008: >Market melts down, swaps pay out >bag $100M personally, $700M for LPs >Wall Street: "How tf did he know?" >Feds + SEC up his ass >close Scion, return capital (sick of the assholes) 2010: >gets a book written about him > "The Big Short" movie gets made >Christian Bale plays you as autistic drum-banging 300IQ spastic >Overnight fame >Relaunch as Scion Asset Management, focus water/gold/farmland >portfolio hits $100M+ by 2016 2025: >become active on Twitter >publicly short $nvda >make 20% within 3 weeks >Shut down Scion >Start Substack newsletter >Generate $10 million+ run rate revenue on day 1 for sharing shitposts
Yeah, the share price dropping sucks, and now with hindsight it was an unsustainable increase for a company that currently isn't making any revenue, nevermind profit. There were obviously a lot of people buying in hoping to make a quick profit. Am hoping for a more gradual sustainable rise next time round. Read the latest investor presentation on their website and there is also a recent 40 minute interview with the MD Shaun Bunn on Crux Investor.
MD's graduate with 200k in debt
“Web MD says I have cancer and here’s a full page I’m gonna ask you to read to confirm it”. Doctors LOVE that.
I’m in aviation so we gotta read NTSB reports after big crashes, NTSB just released photos of the UPS flight takeoff and sure enough, whole fuckin engine ripped off the wing and hit the fuselage causing a fire. Damn MD11 looking like the AA DC10 flight
Wendy’s job posting are now hiring cleaning analysts, cashier associates, VP kitchen coordinators, MD single restaurant managers
Well maybe they shouldn't have had illegal employees. Not sure how CA law works but here in MD it is impossible to hire illegals in the Cannabis companies. We're all licensed by the state and have to have it on us at all times and when they come for inspections they will ask. The owner brought this on himself. So F his lost revenue. That's the risk of violating the law, it might cost you if your caught.
In times like this, I remember the wise words of one Dr Dre, MD. And I quote: Fuck yall. All yall. If yall don’t like me, blow me. ✌️
Bad day to be the wife of the MD who’s been hooking up with the intern
As a future MD, i will follow the great path Dr.Burry took 17 years ago, i will short the whole AI market so you my beloved subreddit can return to profits!!
Fake, I learned from The Big Short that he always signs with "Michael Burry, MD".
He was a Stanford MD resident. Could try that again
Econ/pre-med at UCLA, MD from Vanderbilt, partial residency in neurology at Stanford. You could've taken thirty seconds to look at his wiki but you didn't. This is why you're about $150m poorer than he is.
I can see why he chose to be a MD but won’t practice 😭
>he would be most likely teaching some bs economic class in some mid level university. He has his MD and has kept his license active in CA so its doubtful he would fall back on teaching instead of practicing medicine
You don’t have to be an MD to see the symptoms, listen and look at his body, language and thoughts
“Physician guidelines state that SubQ formulations show higher efficacy in controlling blood glucose and A1C levels. Oral formulations also require your patients to remain fasted providing difficulties with adherence. Why did you decide to prescribe your at risk diabetic patient an oral pill for their diabetes despite guidelines and evidence.” (take a closer look at the MD in my username)
Only the MD-11's Would be like UBER grounding their Oldsmobile fleet